SavedAdd your journal

Journals / Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2022 / Cilt: 9 - Sayı: 2

VITAMIN D DEFICIENCY IN PATIENTS WİTH EARLY BREAST CANCER ACCORDING TO PATHOLOGICAL SUBTYPIES; ONE CENTER EXPERIENCE

ERKEN EVRE MEME KANSERİ HASTALARINDA PATOLOJİK SUBTİPLERE GÖRED VİTAMİN EKSİKLİĞİ; TEK MERKEZ DENEYİM

Gülcan BULUT
Melis RIDVANOĞULLARI DÖNGEL
Pages
256–261
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Vitamin D levels were deficient in 79.1% of the patients (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Vitamin D has been linked to breast cancer risk.
📊
Key Findings & Data:Materials and methods: A total of 208 female patients diagnosed with early breast cancer were included in the study.
💡
Conclusion & Impact:Vitamin D levels were deficient in 79.1% of the patients (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Vitamin D has been linked to breast cancer risk. The first aim of this study is to show vitamin D deficiency in patients with early stage breast cancer and the differences in vitamin D levels according to breast cancer subtypes. Materials and methods: A total of 208 female patients diagnosed with early breast cancer were included in the study. According to pathological subtypes (luminal; HER2 positive; triple negative; triple positive). They were divided into four groups and median vitamin D levels, BMI and file data of breast cancer subtypes were entered into the SPPS program. Results: The median age was 51.37 +/-10.0 The average level of 25 (OH) D3 was 22.3 +/-10.6 nmol / L. Vitamin D levels were deficient in 79.1% of the patients (

Özet

Giriş ve Amaç: D vitamini, meme kanseri riskiyle ilişkilendirilmiştir. Bu çalışmanın birinci amacı erken evre meme kanserli hastalarda D vitamin eksikliğini ve meme kanseri patolojik subtiplerine göre D vitamini düzeylerindeki farklılıkları göstermektedir. Gereç ve Yöntemler: Çalışmaya erken meme kanseri tanısı almış toplam 208 kadın hasta dahil edildi.Patolojik Subtiplere göre (Lüminal; HER2 pozitif; Üçlü negatif; Üçlü pozitif) dört gruba ayrıldı ve meme kanseri alt tiplerinin ortalama D vitamini düzeyleri, VKİ ve dosya verileri SPPS programına girildi. Bulgular: Ortalama yaş 51.37 +/-10.0 idi. 25(OH)D3 düzeyi ortalama 22.3 +/- 10.6 nmol/L idi.Hastaların % 79.1’inde D vitamini seviyeleri eksikti(

🔖

Cite This Article

BULUT, G., DÖNGEL, M. R. (2022). VITAMIN D DEFICIENCY IN PATIENTS WİTH EARLY BREAST CANCER ACCORDING TO PATHOLOGICAL SUBTYPIES; ONE CENTER EXPERIENCE. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 9 - Sayı: 2, 256–261. https://ajindex.com/articles/472650

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Gençtürk N. MEME KANSERİNDE KORUNMA. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi.2010; 72-82
  2. Moorman G and Terry PD. Consumption of dairy products and the risk of breast cancer. Patricia Am J Clin Nutr 2004;80.5–14
  3. Gezmen Karadağ M, Koçyiğit E. D vitamini sentezi emilimi ve metabolizması. Yurttagül SM, editör. D Vitamini
  4. Baskı. Ankara: Türkiye Klinikleri; 2019. p.1-5
  5. Holick MF. Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 1995;17(suppl):107S–11S
  6. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Research, 1941, 1, 191-195. 6-Welsh J. E. Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 2004: 80 (supplement): 1721 7-Çevik B., Beslenme ve Kanser Fırat Tıp Derg/Firat Med J 2017; 22(1): 1-7
  7. Giovanucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer causes control, 2005, 16(2), 83-95
  8. Kıdır M. D vitamininin immun sistem, deri ve kanser ile ilişkisi. Derleme, SDÜ Tıp Fakültesi Dergisi, 2013, 20(4), 158-161 10-Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement. Endocrine Reviews 2012; 33(3): 456492 11- Faustino R. Pérez-López, Peter Chedraui and Javier Haya. Vitamin D Acquisition and BreastCancer Risk. ReproductiveSciences 2009; 16: 7-19
  9. Colston and Feldman DEMONSTRATION OF 1,25-DIHYDROXYVITAMIN D3 RECEPTORS IN HUMAN SKIN BIOPSIES The Journal of Clinical Endocrinology & Metabolism, Volume 51, Issue 6, 1 December 1980, Pages 1463–1465 13-T. S. Sevimli ve ark. Meme kanserinde protein ekspresyon değişimleri Dicle Tıp Dergisi 2013; 40 (1): 161-168 14-M.O Şahin ve ark. 1.25 vitamin D3 ve Resöptörlerinin İnsan Kanserlerindeki Yeri Türkiye E kapotoloji Dergisi 2000; 6 (1,2), 73-79 15- Friederic M and ark. Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor, Vitamin D 1α-Hydroxylase, Vitamin D 24-Hydroxylase, and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers Reprod. Sci. 14, 486–497 (2007)
  10. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement. Endocrine Reviews 2012; 33(3): 456492 17- Welsh J., Vitamin D and breast cancer: Past and present The Journal of Steroid Biochemistry and Molecular Biology 2018; 177 (15-20
  11. Holick MF. Vitamin D: A millennium perspective. J C